Work

Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma

Year: 2023

Type: erratum

Abstract: In the original article, there was a mistake in the Funding statement as published. The correct grant number for the Startup Fund for Scientific Research of Fujian Medical University is 2018QH1202. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Source: Frontiers in Genetics

DOI: 10.3389/fgene.2023.1146199

Authors: Yanbing Yang, Xuenian Ye, Haibin Zhang, Zhaowang Lin, Min Fang, Jian Wang, Yuyan Yu, Xuwen Hua, Hongxuan Huang, Weifeng Xu, Ling Liu, Zhan Lin

Institutions: Fujian Medical University, Mengchao Hepatobiliary Hospital, Dongguan People’s Hospital, Zhengzhou University, Dali University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,295

OpenAlex ID: W4317938584

Cites:

Cited by: 1

Related to: 10